Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 931325, 8 pages
http://dx.doi.org/10.1155/2012/931325
Clinical Study

Impact of Previous ART and of ART Initiation on Outcome of HIV-Associated Tuberculosis

1Clinical Epidemiology Unit, Department of Epidemiology and Clinical Department, National Institute for Infectious Diseases L. Spallanzani, Via Portuense 292, 00149 Rome, Italy
2Institute of Infectious and Tropical Diseases, University of Brescia, 25123 Brescia, Italy
3Division of Infectious Diseases, Department of Internal Medicine, “San Gerardo” Hospital, University of Milano-Bicocca, 20900 Monza, Italy
4Clinic of Infectious Diseases, University of Bari, 70124 Bari, Italy

Received 1 September 2011; Revised 5 January 2012; Accepted 12 January 2012

Academic Editor: Graeme Meintjes

Copyright © 2012 Enrico Girardi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Badri, D. Wilson, and R. Wood, “Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study,” The Lancet, vol. 359, no. 9323, pp. 2059–2064, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. S. D. Lawn, M. Badri, and R. Wood, “Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort,” AIDS, vol. 19, no. 18, pp. 2109–2116, 2005. View at Google Scholar · View at Scopus
  3. S. D. Lawn, L. Myer, D. Edwards, L. G. Bekker, and R. Wood, “Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa,” AIDS, vol. 23, no. 13, pp. 1717–1725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Girardi, G. Antonucci, P. Vanacore et al., “Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection,” AIDS, vol. 14, no. 13, pp. 1985–1991, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Santoro-Lopes, A. M. F. De Pinho, L. H. Harrison, and M. Schechter, “Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy,” Clinical Infectious Diseases, vol. 34, no. 4, pp. 543–546, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. S. Cohen, Y. Q. Chen, M. McCauley et al., “Prevention of HIV-1 infection with early antiretroviral therapy,” The New England Journal of Medicine, vol. 365, no. 6, pp. 493–505, 2011. View at Publisher · View at Google Scholar
  7. E. Girardi, C. A. Sabin, A. D. Monferte et al., “Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America,” Clinical Infectious Diseases, vol. 41, no. 12, pp. 1772–1782, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Kwan and J. D. Ernst, “HIV and tuberculosis: a deadly human syndemic,” Clinical Microbiology Reviews, vol. 24, no. 2, pp. 351–376, 2011. View at Publisher · View at Google Scholar
  9. S. S. Abdool Karim, K. Naidoo, A. Grobler et al., “Timing of initiation of antiretroviral drugs during tuberculosis therapy,” The New England Journal of Medicine, vol. 362, no. 8, pp. 697–706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. F.-X. Blanc et al., “Significant enhancement in survival with early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis,” in Proceedings of the International AIDS Conference, Vienna, Austria, 2010, abstract no. THLBB0106.
  11. E. Girardi, G. Antonucci, P. Vanacore et al., “Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy,” European Respiratory Journal, vol. 24, no. 1, pp. 11–17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. World Health Organization, Treatment of Tuberculosis. Guidelines for National Programmes, Document WHO/CDS/TB 2003/313, World Health Organization, Geneva, Switzerland, 2003.
  13. D. Falzon, Y. Le Strat, F. Belghiti, and A. Infuso, “Exploring the determinants of treatment success for tuberculosis cases in Europe,” International Journal of Tuberculosis and Lung Disease, vol. 9, no. 11, pp. 1224–1229, 2005. View at Google Scholar · View at Scopus
  14. A. Faustini, A. J. Hall, and C. A. Perucci, “Tuberculosis treatment outcomes in Europe: a systematic review,” European Respiratory Journal, vol. 26, no. 3, pp. 503–510, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Caylà, J. A. Caminero, R. Rey, N. Lara, X. Vallés, and H. Galdós-Tangüis, “Current status of treatment completion and fatality among tuberculosis patients in Spain,” International Journal of Tuberculosis and Lung Disease, vol. 8, no. 4, pp. 458–464, 2004. View at Google Scholar
  16. World Health Organization, Treatment of Tuberculosis: Guidelines, World Health Organization, Geneva, Switzerland, 4th edition, 2009, Document WHO/HTM/TB/2009.420.
  17. G. R. Kaufmann, L. Elzi, R. Weber et al., “Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death,” AIDS, vol. 25, no. 4, pp. 441–451, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Komati, P. A. Shaw, N. Stubbs et al., “Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa,” AIDS, vol. 24, no. 12, pp. 1849–1855, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Meintjes, H. Rabie, R. J. Wilkinson, and M. F. Cotton, “Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome and Unmasking of Tuberculosis by Antiretroviral Therapy,” Clinics in Chest Medicine, vol. 30, no. 4, pp. 797–810, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. C. Manabe, R. Breen, T. Perti, E. Girardi, and T. R. Sterling, “Unmasked tuberculosis: part of a disease spectrum after highly active antiretroviral therapy,” Journal of Infectious Diseases, vol. 199, pp. 437–444, 2009. View at Google Scholar